Definitive Healthcare Corp. (DH) Tops Q2 EPS by 2c, provides guidance

Definitive Healthcare Corp. (NASDAQ: DH) reported Q2 EPS of $0.07, $0.02 better than the analyst estimate of $0.05. Revenue for the quarter came in at $60.8 million versus the consensus estimate of $59.18 million.

GUIDANCE:

Definitive Healthcare Corp. sees Q3 2025 EPS of $0.05-$0.06, versus the consensus of $0.06. Definitive Healthcare Corp. sees Q3 2025 revenue of $59-60 million, versus the consensus of $59.236 million.

Adjusted Operating Income is expected to be in the range of $12.5 – $13.5 million.
Adjusted EBITDA is expected to be in the range of $15.5 – $16.5 million, and 26 – 28% adjusted EBITDA margin.
Adjusted Net Income is expected to be $7.5 – $8.5 million.

For earnings history and earnings-related data on Definitive Healthcare Corp. (DH) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Full Circle Lithium closes $5.14M private placement
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance